4928 related articles for article (PubMed ID: 4549213)
21. Inhibitory effect of normal mammalian sera on the rosette formation of human lymphocytes with sheep red blood cells.
Pellegrino MA; Ferrone S; Dierich MP; Pellegrino A; Reisfeld RA
Clin Immunol Immunopathol; 1975 May; 4(1):85-95. PubMed ID: 123840
[No Abstract] [Full Text] [Related]
22. Specificity of cell-mediated cytotoxicity against human melanoma lines: evidence for "non-specific" killing by activated T-cells.
Hersey P; Edwards A; Edwards J; Adams E; Milton GW; Nelson DS
Int J Cancer; 1975 Jul; 16(1):173-83. PubMed ID: 51832
[TBL] [Abstract][Full Text] [Related]
23. Interspecies variability in antibody-dependent cellular cytotoxicity (ADCC).
Zighelboim J; Gale RP
J Immunol; 1974 Oct; 113(4):1145-50. PubMed ID: 4528608
[No Abstract] [Full Text] [Related]
24. [Immunotherapy].
Lejeune FJ; Bernheim JL; Vanwijck R
Acta Chir Belg; 1974 Mar; 73(2):265-93. PubMed ID: 4450923
[No Abstract] [Full Text] [Related]
25. Separation of cells involved in phytohaemagglutinin-induced mitogenesis and cytotoxicity.
Dawkins RL; Zilko PJ
Nature; 1975 Mar; 254(5496):144-5. PubMed ID: 1078883
[No Abstract] [Full Text] [Related]
26. Cellular immunoadsorbents: a simplified technique for separation of lymphoid cell populations.
Kedar E; Ortiz de Landazuri M; Bonavida B
J Immunol; 1974 Mar; 112(3):1231-43. PubMed ID: 4590702
[No Abstract] [Full Text] [Related]
27. Divalent cation requirements as a tool for the study of cell-mediated cytotoxocity systems.
Golstein P
Adv Exp Med Biol; 1976; 66():465-70. PubMed ID: 817576
[No Abstract] [Full Text] [Related]
28. Spontaneous and antibody-dependent cellular cytotoxicity in melanoma patients and healthy control presons.
Peter HH; Knoop F; Kalden JR
Z Immunitatsforsch Exp Klin Immunol; 1976 Apr; 151(3):263-81. PubMed ID: 134545
[TBL] [Abstract][Full Text] [Related]
29. Sequential studies on cell-mediated tumor immunity and blocking serum activity in ten patients with malignant melanoma.
Hellström I; Warner GA; Hellström KE; Sjögren HO
Int J Cancer; 1973 Mar; 11(2):280-92. PubMed ID: 4790696
[No Abstract] [Full Text] [Related]
30. Potentiation and arming of lymphocyte mediated immunity by sera from melanoma patients.
Vanwijck R; Bouillenne C; Malek-Mansour S
Eur J Cancer (1965); 1975 Apr; 11(4):267-76. PubMed ID: 1079770
[No Abstract] [Full Text] [Related]
31. Significance of antigen binding by T cells.
Charreire J; Bach JF
Transplant Proc; 1973 Dec; 5(4):1735-7. PubMed ID: 4130079
[No Abstract] [Full Text] [Related]
32. Allograft response in vitro.
Häyry P; Andersson LC; Nordling S; Virolainen M
Transplant Rev; 1972; 12():91-140. PubMed ID: 4143965
[No Abstract] [Full Text] [Related]
33. A B7-1-transfected human melanoma line stimulates proliferation and cytotoxicity of autologous and allogeneic lymphocytes.
Sulé-Suso J; Arienti F; Melani C; Colombo MP; Parmiani G
Eur J Immunol; 1995 Oct; 25(10):2737-42. PubMed ID: 7589065
[TBL] [Abstract][Full Text] [Related]
34. Rosette formation by guinea pig thymocytes and thymus derived lymphocytes with rabbit red blood cells.
Stadecker MJ; Bishop G; Wortis HH
J Immunol; 1973 Dec; 111(6):1834-7. PubMed ID: 4201559
[No Abstract] [Full Text] [Related]
35. [Immunology of malignant melanomas].
Schieferstein G
Fortschr Med; 1976 May; 94(14):833-7. PubMed ID: 1270047
[TBL] [Abstract][Full Text] [Related]
36. Immune responses induced by human malignant melanoma in the rabbit.
Goodwin DP; Hornung MO; Leong SP; Krementz ET
Surgery; 1972 Nov; 72(5):737-43. PubMed ID: 4117015
[No Abstract] [Full Text] [Related]
37. Destruction of cultivated melanoma cells by lymphocytes from healthy Black (North American Negro) donors.
Hellström I; Hellström KE; Sjögren HO; Warner GA
Int J Cancer; 1973 Jan; 11(1):116-22. PubMed ID: 4790830
[No Abstract] [Full Text] [Related]
38. T cells can bind antigen via cytophilic IgM antibody made by B cells.
Webb SR; Cooper MD
J Immunol; 1973 Jul; 111(1):275-7. PubMed ID: 4541324
[No Abstract] [Full Text] [Related]
39. Anti-tumor immunoreactivity in patients with malignant melanoma.
Nairn RC; Nind AP; Guli EP; Davies DJ; Little JH; Davis NC; Whitehead RH
Med J Aust; 1972 Feb; 1(9):397-403. PubMed ID: 4554232
[No Abstract] [Full Text] [Related]
40. Membrane markers of lymphocytes in lymphomas, melanoma and lupus erythematosus.
Edelson RL
Int J Dermatol; 1976 Oct; 15(8):577-86. PubMed ID: 786913
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
